DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20161228

Estimation of serum glutamic oxaloacetic transaminase, serum glutamic-pyruvic transaminase, gamma-glutamyl transferase and cholesterol levels in prolonged (30 years) daily consumption coffee in people

J. Sudha Rani, D. S. S. K. Raju

Abstract


Background: Although prolonged (30years) coffee consumption has been associated with reduced or increased frequency of liver (SGOT, SGPT, GGT) enzymes and cholesterol levels, it is unclear whether the effect is from coffee or caffeine.
Methods: A self-administered questionnaire ascertained lifestyle characteristics, including alcohol consumption, cigarette smoking, Diabetes mellitus and Dietary habits. As for drinking habit, examinees were first asked about their current drinking frequency (none, 1-2 times/ week, or almost daily) past or current smokers about the number of cigarettes smoked per day and the duration of smoking in years. As regards coffee, examinees were asked their usual daily intake in cups.


Results: A total No of 200 cases were studied by dividing them into two group’s controls and cases. The results so obtain were compared with 50 healthy controls (not to consumed caffeine contained things that include nor coffee, tea, any type of cola’s). Statistical evaluation was carried out to confirm any deviation from the normal values. In men the mean serum SGOT, SGPT, GGT and cholesterol of cases is having higher level as compared to the mean value of controls. This increase is statistically highly significant (SGOT<0.0001, SGPT=0.045, GGT=0.0043, cholesterol<0.0001). In women’s the mean serum SGOT, SGPT, GGT and cholesterol of Cases is having higher level as compared to the mean value of Controls. This increase is statistically significant (SGOT< 0.05, SGPT=0.0319, GGT <0.0001, cholesterol: <0.0001).


Conclusion: It has been shown from this study that prolonged daily consumption of coffee in many people it results increasing of levels of serum concentrations of the SGOT, SGPT, GGT and Cholesterol. It is observed that liver enzymes and cholesterol could be a target for caffeine or other components of coffee.

 

Keywords


SGOT, SGPT, GGT, Cholesterol, Caffeine and coffee

Full Text:

PDF

References


International coffee organization (ICO). Statistics. Breakdown of exports of green arabica and green robusta of countries exporting significant volumes of both types of coffee. June 2009, January 2011. www.ico.org (accessed January 21, 2011).

Yeretzian C, Jordan A, Lindinger W. analysing the headspace of coffee by proton transfer reaction mass spectrometry. Int. J. Mass Spectr. 2003;223-224:115-139.

Clarke RJ. Coffee: green coffee/ roast and ground. In: encyclopaedia of Food Science and Nutrition, 2nd ed, Caballero B, Trugo LC, Finglas P, eds. Oxford: Academic Press. 2003;3.

http://www.coffeeresearch.org/agriculture/coffeeplant.htm""Arabica and Robusta Coffee Plant. Coffee Research Institute. Retrieved25 August 2011.

ABIC, 2011. Brazilian Association of Coffee Industry (Technical information).

Fukushima Y, Ohie T, Yonekawa Y, Yonemoto K, Aizawa H, Mori Y et al. Coffee and green tea as a large source of antioxidant polyphenols in the Japanese population. J Agric Food Chem. 2009; 25;57(4):1253-97.

Bättig K. The physiological effects of coffee consumption. In: Clifford MN and Wilson KC (Eds) Coffee: botany, biochemistry and production of beans and beverage. Croom Helm, London. 1985;394-439.

Schilter B, Cavin C, Tritscher A, Constable A. Health effects and safety considerations. In: Clarke RJ and Vitzthum OG (Eds) Coffee: Recent Developments. Blackwell Science, Oxford. 2001; 165-183.

Ashihara H, Monteiro AM, Gillies FM, Crozier A Biosynthesis of caffeine in leaves of coffee. Plant Physiol. 1996;111:747-53.

Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992;17(2):139-70.

Methylxanthines and pain by Jana S in Handbook of experimental pharmacology. 2011.

Belitz H, Grosch W, Peter Schieberl, Food Chemistry, 4th revised and extended ed.

Shimizu MM, Mazzafera P. A role for trigonelline during imbibition and germination of coffee seeds. Plant Biol. 2000;2: 605-611.

De Maria CAB, Trugo LC, Moreira RFA, Werneck CC. Composition of green coffee fractions and their contribution to the volatile profile formed during roasting. Food Chem.1994;50:141-5.

Ky CL, Guyot B, Louarn J, Hamon S, Noirot M Trigonelline inheritance in the interspecific Coffeapseudozanguebariae x C. liberica var. dewevrei cross Theor. Appl. Genet. 2001;102:630-4.

Clifford MN. Chlorogenic acid their complex nature and routine determination in coffee beans, J. Sci. Food Agr. 1979;27:73-84.

Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs JDR et al. Intake of antioxidants in coffee; wine and vegetables are correlated with plasma carotenoids in human. J. Am. Nutr. Sci. 2004;134:562-7.

Wen X, Takenaka M, Murota M, Homma S. Antioxidative activity of a zinc chelating substances in coffee. BioSci. Biotechnol. Biochem. 2004;68(11):2313-8.

Zhu H, Shako H, Zhang Z, Wang W, Yao S. Laser flash photolysis study on antioxidant properties of hydroxycinnamic acid derivative, Radiat Environ. 2006;45:73-7.

Manach C, Scallbert A, Morand C, Remesy C, Jimcne L. Ploy phenol food: source and bioavilability, Am. J. Clin. Nutr. 2004;79:727-47.

Abidoff M. Effect of chlorogenic acid administration on postprandial blood glucose levels. Moscow Center Clin. 1999;161-4.

Salazar-Martinez E, Willet W, Ascherio A, Leitzmann M, Manson J, Hu FB. Coffee consumption and risks of type 2 diabetes in men women diabetes. 2003;52:A72.

Vandam RM, Feskens EJ. Coffee consumption and risks of type2 diabetes. Mellitus Lancet. 2002;360: 144-8.

Variyar PS, Ahmad R, Bhat R, Niyas N, Sharma A. Flavoring components of raw monsonedarabica coffee and their changes during radiation process. J. Agric. Food chem. 2003;51:7945-50.

Trugo LC, Macrae R. A study of the effect of roasting on the Chlorogenic acid composition of instant coffees. Analyst. 1984;109:263266.

Clifford MN, Wight J. The measurement of feruloylquinic acids and caffeoylquinic acids in coffee beans development of the techniques and its preliminary application to green coffee beans. J. Sci. Food. Agric. 1976;27:73-84.

MORISHITA H, KIDO R. Anti-oxidant activities of chlorogenic acid (PDF). 16th international colloqu. Chem. Coffee, Kyoto. 1995.

Sherwin JE. Liver function; in Kaplan LA, Pesce AJ (eds): Clinical Chemistry. Theory, analysis and Correlation. St Louis, Mosby. 1989. 359-72.

Newton R, Broughton LJ, Lind MJ, Morrison PJ, Rogers HJ, Bradbrook ID. Plasma and salivary pharmacokinetics of caffeine in man. European journal of clinical pharmacology. 1981;21(1):45-52.

Caffeine. The Pharmacogenetics and Pharmacogenomics Knowledge Base. Retrieved25 October 2010.

Arnaud MJ: The pharmacology of caffeine. Prog Drug Res. 1987;31:273-313.

[Articles:17221922,In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios by Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini E K in Biomedical chromatography : BMC (2007).

Tietz N.(Ed), Fundamentals of Clinical Chemistery, W.B.Saunders Co. Philadeipha PA. 1986.

Bradley DW, Maynard JE, Emery G and Webster H. Transaminase activities in serum of long-term hemodialysis patients. Clin,Chem. 1972;18:1442.

IFCC Methods for the measurement of catalytic concentrations of enzymes. J. Clin,Chem. ClinBiochem. 1986;24:497.

Allain CC, Poon LS, Chan CSG, Richmond W. and Fu P. Enzymatic determination of total serum cholesterol. Clin,Chem. 1974;20;470.

Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005;128:24-32.

Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006;166:1190-5.

Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol. 2003;13:419 -23.

Urgert R, Meyboom S, Kuilman M, Rexwinkel H, Vissers MN, Klerk M et al. Comparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomized controlled trial. BMJ 1996;313:1362-6.

Weusten-Van der Wouw MPME, Katan MB, Viani R, Huggett AC, Liardon R, Lund-Larsen PG, Thelle DS, Ahola I, Aro A, Meyboom S & Beynen AC: Identity of the colesterol-raising factor from boiled coffee and its effects on liver function enzymes. J. Lipid. Res. 1994;35:721-33.

Carola R, Harley JP, Charles R, Naback P. Functions of the liver. In: Human Anatomy and Physiology, McGraw-Hill Publishing Company, New York 1990;707-12.

Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ.Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. 2001;15:153(4):353-62.

Coffee and cholesterol - Health - Heart health | NBC News.

Arnesen E, Huseby NE, Brenn T, Try K. The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest. 1986;46:63-70.

Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol. 2001;54:823-9.

Freedman ND, Curto TM, Lindsay KL, Wright EC, Sinha R, Everhart JE. Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology. 2011;140:1961-9.

Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998;27:438-43.

Wahllander A, Renner E, Preisig R. Fasting plasma caffeine concentration. A guide to the severity of chronic liver disease. Scand J Gastroenterol. 1985; 20:1133-41.

Inoue M, Yoshimi I, Sobue T, Tsugane S, JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005; 97:293-300.

Poikolainen K, Vartiainen E. Determinants of gammaglutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol. 1997;146:1019-24.